SCYNEXIS, Inc. provides pharmaceutical products. The Company discovers, develops, and distributes intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans. SCYNEXIS serves customers in the United States.

Q2 2024

Q1 2024

Q4 2023

Q3 2023

United States

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company develops next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. Zynerba Pharmaceuticals serves the healthcare sector and patients in the United States.

Assembly Biosciences Inc. is a biopharmaceutical company. The Company is focused in the field of infectious diseases such as the Hepatitis B virus (HBV) and clostridium difficile (CDAD). Assembly is developing two proprietary platforms: an HBV-cure platform focused on oral drugs with novel direct-acting mechanisms, and an orally-delivered microbiome therapeutics platform for treating CDAD.

Aclaris Therapeutics, Inc. operates as a clinical-stage specialty pharmaceutical company. The Company focuses on identifying, developing, and commercialization topical drugs to address significant unmet needs in dermatology. Aclaris Therapeutics offers a topical therapy for the treatment of seborrheic keratosis and other verrucoid lesions of the skin.

Odonate Therapeutics, Inc. operates as a pharmaceutical company. The Company develops an oral chemotherapy drugs for the treatment of cancer. Odonate Therapeutics offers its services worldwide.

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company develops, discovers, and commercializes aesthetics and dermatology based products for inflammatory skin diseases, tissue injury, and unwanted light-pigmented hair reduction. Sienna Biopharmaceuticals serves patients in the United States and Italy.

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of antibiotics. The Company develops medicine for serious community-acquired bacterial infections. Paratek Pharmaceuticals' products treat patients in both the community and hospital setting.

NGM Biopharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing novel therapeutics based on scientific understanding of key biological pathways underlying cardio-metabolic, liver, oncologic, and ophthalmic diseases. NGM Biopharmaceuticals serves medical industry in the United States.

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating safe and effective branded and generic prescription, and over-the-counter products targeted exclusively for women. The Company develops three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies.

Iterum Therapeutics Public Limited Company operates as a a clinical-stage pharmaceutical company. The Company develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. Iterum Therapeutics serves physicians and patients worldwide.

Kubota Pharmaceutical Holdings Co.,Ltd. operates as a holding company. The company, through its subsidiaries, specializes in identifying and developing therapeutics to treat the ophthalmic disorders. Kubota Pharmaceutical Holdings serves customers worldwide.

Albert David Ltd. manufactures a variety of pharmaceutical products, vitamins, external application lotions, I.V. sets and disposable syringes and needles. The Company's leading products include "Plcentrex Lotion", "Adilox Capsules", "Sioplex Capsules", "Siotone" (a fitness capsule) and "Adliv Forte Capsule/Syrup" (for liver disorder).

Hwail Pharm Co., Ltd. produces pharmaceutical raw materials.  The Company's products include Talniflumate, Alibendol, and Oxatomide.  Hwail supplies these materials to companies dealing with finished pharmaceutical products.

Furen Pharmaceutical Group Industry Co., Ltd. is primarily engaged in the operation and management of its subsidiary, namely, Henan Furentang Pharmaceutical Co., Ltd., which manufactures proprietary pharmaceuticals.

Furen Pharmaceutical Grp Industry (600781 CH)

Genovate Biotechnology Co., Ltd. produces and markets antimicrobial agents, antineoplastic agents, cardiovascular system drugs, digestive system drugs, external agents, nervous system drugs, non-addictive analgesics and anti-inflammatory drugs, urinary system drugs, and vitamins.

Dongsung Pharmaceutical Co., Ltd. manufactures pharmaceutical products, such as antibiotics and dermatological medicines. The Company also produces and markets cosmetic products.

Kukje Pharma Ind. Co., Ltd. manufactures medical drugs.  The Company's products include antibiotics, vitamins, nutritional agents, and other drugs for supply to hospitals.  Kukje Pharma Ind. also sells apartments.

Y.S.P. Southeast Asia Holdings Bhd is an investment holding company. The Company, through its subsidiaries, imports, exports, manufactures and trades pharmaceutical and veterinary products.

Ind-Swift Laboratories Ltd. manufactures bulk drugs and intermediates.  The Company's product portfolio includes anti-infective, anti-allergy, analgesic and cardiovascular medicines.

Estechpharma Co., Ltd. manufactures medical drugs.  The Company's products include alcohol treatment, anti-inflammatory, anti-ulcerative, anti-thrombosis, and anti-diabetic drugs.

Nectar Lifesciences Ltd. manufactures active pharmaceutical ingredients.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00